1 the difference between measured glycosylated hemoglobin (Hb A 1c ) and Hb A 1c predicted from fructosamine, has been used to quantify nonglycemic differences in formation of Hb A 1c between individuals, but the technique is controversial (1 ). An increased GG in patients with diabetes has been associated with nephropathy diagnosed primarily by proteinuria (2) (3) (4) . The GG can be calculated irrespective of glycemia, that is, in normoglycemic as well as hyperglycemic individuals. We therefore hypothesized that, in individuals without diabetes, chronic kidney disease (CKD) would be associated with an increased GG compared with those without CKD.
We studied a nonprobability convenience sample, after applying exclusion criteria, of 949 patients in the community whose CKD stage was based on estimated glomerular filtration rate (eGFR) (5 ). Over a 4-month period, we analyzed samples from primary care mostly on receipt and all within 24 h. Exclusion criteria were diabetes mellitus, pregnancy, age Ͻ16 years, hemoglobinopathy, unknown ethnicity or not of white or South Asian ethnicity, hemoglobin Յ9.0 g/dL, and albumin Ͻ3.0 or Ͼ5.0 g/dL.
Laboratory analyses were performed by routine methodology in an accredited laboratory with acceptable and stable performance throughout the study period. Hemoglobin (flow cytometry, Sysmex XN-10 ® , Sysmex Corp.), Hb A 1c (ion-exchange HPLC, National Glycohemoglobin Standardization Program certified, G7 HPLC analyzer, Tosoh Corp.), fasting glucose (hexokinase), creatinine (compensated kinetic Jaffe with rateblanking), albumin (bromocresol green), and fructosamine (nitrotetrazolium blue) were measured (Modular ® P analyzer, Roche Diagnostics). CKD stages Ͻ3, 3, 4, and 5 were based on eGFR levels of Ն60, 30 -59, 15-29, and Ͻ15 mL ⅐ min Ϫ1 ⅐ (1.73 m 2 ) Ϫ1 , respectively. All patients were in CKD stage Յ3 except for 2 (0.2%) with CKD 4. Because of the small numbers of those in CKD stage Ͼ3, the 2 patients were removed, with further analysis examining only those in stage 3 and below. Permission for data to be published has been granted by the Royal Wolverhampton NHS Trust Caldicott Guardian.
We calculated the GG by converting fructosamine into a standardized normal deviate by subtracting the mean fructosamine from each value and dividing the result by the SD of fructosamine (4 ). (Table 1) . Those with CKD stage 3, compared to those with CKD stage Ͻ3, were older, but despite higher glycemic markers, their GG was similar (Table 1) . When controlled for independent variables and compared to CKD stage Ͻ3, the GG was not associated with CKD (model 1), and neither was Hb A 1c (model 2). The only variable that significantly predicted CKD stage was age. These data suggest that the GG is not associated with CKD in nondiabetic individuals, defined according to eGFR. 
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